By combining a meta-analysis with the largest genome-wide association (GWA) meta-analysis datasets, Kar et al. (2016) found that SMC2 is associated with susceptibility to breast and ovarian cancer. This evidence concerns the gene SMC2 and ovarian carcinoma.